SCHEMBL725097

SCHEMBL725097

O=C(O)CCCCCNC(=O)CCSSc1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.55
ALDH1A1 P00352 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
HDAC6 Q9UBN7 3/20 0.45
HDAC1 Q13547 3/20 0.45
HDAC2 Q92769 3/20 0.45
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC10 Q969S8 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC8 Q9BY41 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29276715 1.00 HPGD (0.55) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL29276718 0.95 HPGD (0.57) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL19444563 0.95 HPGD (0.56) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL29380577 0.94 HPGD (0.57) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL155342 0.94 HPGD (0.57) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL19512851 0.92 HPGD (0.51) HPGDALDH1A1SMN1; SMN2LMNATSHR
Succinimide SCHEMBL28349191 0.91 HPGD (0.47) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL12248525 0.91 HPGD (0.50) HPGDALDH1A1SMN1; SMN2LMNAHDAC6
SCHEMBL14341782 0.90 HPGD (0.52) HPGDALDH1A1SMN1; SMN2LMNATSHR
SCHEMBL10310074 0.90 HPGD (0.61) HPGDALDH1A1SMN1; SMN2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897498-A RNA preservation and recovery from immobilized cells 贝克顿迪金森公司 2024-04-16 CN claimed
EP-3965887-B1 ANTIMICROBIAL CHITOSAN UNIV GENEVE (CH) 2024-02-28 EP claimed
CN-115997016-A Composition comprising nucleic acid nanoparticles having modular functional groups 西克斯福德生物科学有限公司 2023-04-21 CN claimed
CN-115591010-A High-activity stem cell biological injectable carrier material and preparation method thereof 华东理工大学(CN) 2023-01-13 CN claimed
CN-115551638-A Method and system for physical expansion and imaging of biological samples 耶鲁大学 2022-12-30 CN claimed
EP-2968440-B1 CYTOTOXIC AND ANTI-MITOTIC COMPOUNDS, AND METHODS OF USING THE SAME ZYMEWORKS INC (CA) 2019-06-05 EP claimed
EP-3171171-B1 RECOMBINANT DEAMIDATED GLIADIN ANTIGEN BIO RAD LABORATORIES (US) 2018-07-18 EP claimed
EP-2197783-B1 COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF SEOUL NATIONAL UNIV INDUSTRY FOUNDATION (KR) 2018-07-11 EP claimed
US-9849190-B2 Peptide having cancer selective translocation function and use thereof SNU R&DB FOUNDATION (KR) 2017-12-26 US claimed
EP-2788760-B1 RECOMBINANT DEAMIDATED GLIADIN ANTIGEN BIO RAD LABORATORIES INC (US) 2017-02-15 EP claimed
EP-0832201-B1 A SAMPLE PRESENTATION APPARATUS FOR MASS SPECTROMETRY UNIV ARIZONA (US) 2005-10-05 EP claimed
WO-2005089826-A1 BONE GRAFT AND SCAFFOLDING MATERIALS IMMOBILIZED WITH OSTEOGENESIS ENHANCING PEPTIDES ON THE SURFACE SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2005-09-29 WO claimed
EP-1098664-B1 CONJUGATES FOR TREATING INFLAMMATORY DISORDERS AND ASSOCIATED TISSUE DAMAGE OSPREY PHARMACEUTICALS LTD (CA) 2003-08-06 EP claimed
WO-2002061045-A2 SIMPLIFIED METHOD FOR INDEXING AND DETERMINING THE RELATIVE CONCENTRATION OF EXPRESSED MESSENGER RNAS DIGITAL GENE TECHNOLOGIES, INC. (US) 2002-08-08 WO claimed
US-20020012922-A1 Simplified method for indexing and determining the relative concentration of expressed messenger RNAs NEUROME, INC. 2002-01-31 US claimed
WO-2001083696-A2 METHODS FOR RAPID ISOLATION AND SEQUENCE DETERMINATION OF GENE-SPECIFIC SEQUENCES DIGITAL GENE TECH INC (US) 2001-11-08 WO claimed
EP-0751959-B1 MODIFIED POLYPEPTIDES WITH INCREASED BIOLOGICAL ACTIVITY NEW ENGLAND DEACONESS HOSPITAL (US) 2000-01-05 EP claimed
EP-0751959-A1 MODIFIED POLYPEPTIDES WITH INCREASED BIOLOGICAL ACTIVITY NEW ENGLAND DEACONESS HOSPITAL (US) 1997-01-08 EP claimed
US-5580853-A ERYTHROPOIETIN WITH ATTACHED HETEROBIFUNCTIONAL CROSSLINKING REAGENT CONTAINING CLEAVABLE DISULFIDE BOND GROUP NEW ENGLAND DEACONESS HOSPITAL (US) 1996-12-03 US claimed
WO-1995025746-A1 MODIFIED POLYPEPTIDES WITH INCREASED BIOLOGICAL ACTIVITY NEW ENGLAND DEACONESS HOSPITAL (US) 1995-09-28 WO claimed